<rss version="2.0"><channel><title>Yahoo! Finance: APS.TO News</title><copyright>Copyright (c) 2017 Yahoo! Inc. All rights reserved.</copyright><link>http://finance.yahoo.com/q/h?s=aps.to</link><description>Latest Financial News for APTOSE BIOSCIENCES INC</description><language>en-US</language><lastBuildDate>Thu, 29 Dec 2016 13:15:00 GMT</lastBuildDate><image><url>http://l.yimg.com/a/i/brand/purplelogo/uh/us/fin.gif</url><title>Yahoo! Finance: APS.TO News</title><link>http://finance.yahoo.com/q/h?s=aps.to</link><width>144</width><height>45</height></image><item><title>IIROC Trade Resumption - APS</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/iiroc-trade-resumption-aps-131500725.html</link><description /><guid isPermaLink="false">yahoo_finance/3243267234</guid><pubDate>Thu, 29 Dec 2016 13:15:00 GMT</pubDate></item><item><title>IIROC Trade Resumption - APS</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/iiroc-trade-resumption-aps-131500177.html</link><description /><guid isPermaLink="false">yahoo_finance/2360291799</guid><pubDate>Thu, 29 Dec 2016 13:15:00 GMT</pubDate></item><item><title>IIROC Trading Halt - APS</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/iiroc-trading-halt-aps-131300858.html</link><description /><guid isPermaLink="false">yahoo_finance/2094534205</guid><pubDate>Thu, 29 Dec 2016 13:13:00 GMT</pubDate></item><item><title>IIROC Trading Halt - APS</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/iiroc-trading-halt-aps-131300757.html</link><description /><guid isPermaLink="false">yahoo_finance/675417445</guid><pubDate>Thu, 29 Dec 2016 13:13:00 GMT</pubDate></item><item><title>Aptose Biosciences Provides Update on APTO-253 Development</title><link>http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=1288r4amj/*http://www.publicnow.com/view/8A18673E1ABB702102DDA568BF712F4A7207A6CC</link><description>[at noodls] - SAN DIEGO and TORONTO, Dec. 29, 2016 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing new therapeutics and molecular diagnostics that target the ...</description><guid isPermaLink="false">yahoo_finance/1100804183</guid><pubDate>Thu, 29 Dec 2016 13:12:08 GMT</pubDate></item><item><title>Aptose Biosciences Provides Update on APTO-253 Development</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/aptose-biosciences-provides-apto-253-130000215.html</link><description>[GlobeNewswire] - SAN DIEGO and TORONTO, Dec. 29, 2016-- Aptose Biosciences Inc., a clinical-stage company developing new therapeutics and molecular diagnostics that target the underlying mechanisms of cancer, today provided ...</description><guid isPermaLink="false">yahoo_finance/3642804434</guid><pubDate>Thu, 29 Dec 2016 13:00:00 GMT</pubDate></item><item><title>Aptose Biosciences reports 3Q loss</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/aptose-biosciences-reports-3q-loss-005147522.html</link><description /><guid isPermaLink="false">yahoo_finance/1146342254</guid><pubDate>Tue, 15 Nov 2016 00:51:47 GMT</pubDate></item><item><title>Aptose Biosciences Reports Financial Results for the Third Quarter Ended September 30, 2016</title><link>http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=128oj7lbe/*http://www.publicnow.com/view/C36A204D6C915E50D837484F85353930B9CCAECD</link><description>[at noodls] - SAN DIEGO and TORONTO, Nov. 14, 2016 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing new therapeutics and molecular diagnostics that target the ...</description><guid isPermaLink="false">yahoo_finance/2133117944</guid><pubDate>Tue, 15 Nov 2016 00:37:07 GMT</pubDate></item><item><title>Aptose Biosciences Reports Financial Results for the Third Quarter Ended September 30, 2016</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/aptose-biosciences-reports-financial-results-002226920.html</link><description>[GlobeNewswire] - SAN DIEGO and TORONTO, Nov. 14, 2016-- Aptose Biosciences Inc., a clinical-stage company developing new therapeutics and molecular diagnostics that target the underlying mechanisms of cancer, today announced ...</description><guid isPermaLink="false">yahoo_finance/61283263</guid><pubDate>Tue, 15 Nov 2016 00:22:26 GMT</pubDate></item><item><title>Q3 2016 Aptose Biosciences Inc Earnings Release - After Market Close</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/research/earncal/20161114.html?t=aps.to</link><description /><guid isPermaLink="false">yahoo_finance/873914653</guid><pubDate>Mon, 14 Nov 2016 12:07:02 GMT</pubDate></item><item><title>Aptose To Release Third Quarter Ended September 30, 2016 Financial Results and Hold Conference Call on November 15, 2016</title><link>http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=1286c2ufe/*http://www.publicnow.com/view/60916A4830A8D1B29F985DABFABE98BF6CD22A4B</link><description>[at noodls] - SAN DIEGO and TORONTO, Nov. 10, 2016 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Aptose) (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing new therapeutics and molecular diagnostics that target ...</description><guid isPermaLink="false">yahoo_finance/779292158</guid><pubDate>Thu, 10 Nov 2016 12:11:05 GMT</pubDate></item><item><title>Aptose To Release Third Quarter Ended September 30, 2016 Financial Results and Hold Conference Call on November 15, 2016</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/aptose-release-third-quarter-ended-120000945.html</link><description>[GlobeNewswire] - SAN DIEGO and TORONTO, Nov. 10, 2016-- Aptose Biosciences Inc., a clinical-stage company developing new therapeutics and molecular diagnostics that target the underlying mechanisms of cancer, will release ...</description><guid isPermaLink="false">yahoo_finance/2224949520</guid><pubDate>Thu, 10 Nov 2016 12:00:00 GMT</pubDate></item><item><title>Aptose to Present New APTO-253 Data at the 2016 ASH Annual Meeting</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/aptose-present-apto-253-data-201500154.html</link><description>[GlobeNewswire] - SAN DIEGO and TORONTO, Nov. 03, 2016-- Aptose Biosciences Inc., a clinical-stage company developing new therapeutics and molecular diagnostics that target the underlying mechanisms of cancer, today announced ...</description><guid isPermaLink="false">yahoo_finance/806159498</guid><pubDate>Thu, 03 Nov 2016 20:15:00 GMT</pubDate></item><item><title>Aptose Biosciences Inc Conference Call to Discuss on FDA Clinical Hold of APTO-253 scheduled for 8:30 am ET today</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/cc/9/154239.html</link><description /><guid isPermaLink="false">yahoo_finance/2476011472</guid><pubDate>Thu, 13 Oct 2016 12:30:00 GMT</pubDate></item><item><title>Aptose Provides Update on FDA Clinical Hold of APTO-253</title><link>http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=128fa26k0/*http://www.publicnow.com/view/146BC11F3B946AA3089AF89794789D264AC1A852</link><description>[at noodls] - SAN DIEGO and TORONTO, Oct. 13, 2016 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing new therapeutics and molecular diagnostics that target the ...</description><guid isPermaLink="false">yahoo_finance/3795445095</guid><pubDate>Thu, 13 Oct 2016 11:10:03 GMT</pubDate></item><item><title>Aptose Provides Update on FDA Clinical Hold of APTO-253</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/aptose-provides-fda-clinical-hold-110000845.html</link><description>[GlobeNewswire] - SAN DIEGO and TORONTO, Oct. 13, 2016-- Aptose Biosciences Inc., a clinical-stage company developing new therapeutics and molecular diagnostics that target the underlying mechanisms of cancer, today announced ...</description><guid isPermaLink="false">yahoo_finance/1096424855</guid><pubDate>Thu, 13 Oct 2016 11:00:00 GMT</pubDate></item><item><title>Aptose Submits Formal Response to Clinical Hold for APTO-253</title><link>http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=1285edpnh/*http://www.publicnow.com/view/6B5FBAC4B989432BC1690DC967798F0100EE30F3</link><description>[at noodls] - SAN DIEGO and TORONTO, Sept. 12, 2016 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing new therapeutics and molecular diagnostics that target the ...</description><guid isPermaLink="false">yahoo_finance/2564577075</guid><pubDate>Mon, 12 Sep 2016 12:18:07 GMT</pubDate></item><item><title>Edited Transcript of APS.TO earnings conference call or presentation 9-Aug-16 9:00pm GMT</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/edited-transcript-aps-earnings-conference-164855529.html</link><description /><guid isPermaLink="false">yahoo_finance/3838680138</guid><pubDate>Wed, 17 Aug 2016 16:48:55 GMT</pubDate></item><item><title>Aptose Biosciences reports 2Q loss</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/aptose-biosciences-reports-2q-loss-235145229.html</link><description /><guid isPermaLink="false">yahoo_finance/3971095626</guid><pubDate>Tue, 09 Aug 2016 23:51:45 GMT</pubDate></item><item><title>Aptose Biosciences reports 2Q loss</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/aptose-biosciences-reports-2q-loss-235145375.html</link><description /><guid isPermaLink="false">yahoo_finance/2170877566</guid><pubDate>Tue, 09 Aug 2016 23:51:45 GMT</pubDate></item></channel></rss>